Filing Details

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) TransMedics Group Inc -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 89377M109 -------------------------------------------------------- (CUSIP Number) December 31, 2022 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 89377M109 (1)Names of reporting persons. Sandhill Capital Partners LLC d/b/a Sandhill Investment Management I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) 22-0444918 (2) Check the appropriate box if a member of a group (a) [ ] (b) [ ] (3) SEC use only (4) Citizenship or place of organization New York Number of shares beneficially owned by each reporting person with: (5) Sole voting power 181412 (6) Shared voting power 0 (7) Sole dispositive power 1203750 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 1203750 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 3.8% (12) Type of reporting person IAItem 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- TransMedics Group Inc Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 200 MINUTEMAN ROAD ANDOVER MA 01810 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- Sandhill Capital Partners LLC d/b/a Sandhill Investment Management 2(b) Address or principal business office or, if none, residence: ----------------------------------------------------------------------- 40 Fountain Plaza, Suite 1300, Buffalo, NY 14202 2(c) Citizenship: -------------------------------------------------------------------- New York, USA 2(d) Title of class of securities: ------------------------------------------------------------------- Common Stock 2(e) CUSIP No.: 89377M109Item 5. Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [X]. Item 6. Ownership of More than 5 Percent on Behalf of Another Person Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Item 8. Identification and Classification of Members of the Group Item 9. Notice of Dissolution of Group Item 10. Certifications By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 10, 2023 Signature: Ryan Andrew Myers ------------------------------------------- Name/Title Chief Compliance Officer